Advertisement

Clinical Rheumatology

, Volume 32, Issue 5, pp 629–633 | Cite as

Severe deficiency of 25-hydroxyvitamin D3 (25-OH-D3) is associated with high disease activity of rheumatoid arthritis

  • Hans-Jacob Haga
  • Anne Schmedes
  • Yusuf Naderi
  • Alicia Martin Moreno
  • Elisabeth Peen
Original Article

Abstract

This study aims to measure the serum level of 25-hydroxyvitamin D3 (25-OH-D3) in 302 patients with rheumatoid arthritis (RA), studying the association to disease activity. Three hundred two RA patients underwent clinical examination and serological analysis. 25-Hydroxyvitamin D3 was determined by high-performance liquid chromatography–tandem mass spectrometry. Vitamin D3 deficiency defined as serum levels of 25-hydroxyvitamin D3 below 50 nmol/l was detected in 101 RA patients (33.4 %). There was no significant correlation between the serum level of 25-hydroxyvitamin D3 and Disease Activity Score 28 (DAS28) (3w) score. In a subpopulation of RA patients with very low serum level of 25-OH-D3 (≤15 nmol/l) (n = 15), there were significant differences compared to patients with normal 25-OH-D3 (n = 200): higher percentage of patients with positive rheumatoid factor (100.0 versus 77.5 %; p = 0.05), higher CRP (28.7 versus 14.8 mg/l; p = 0.001), higher number of patients treated with at least three disease-modifying antirheumatic drugs (DMARDs) (40.0 versus 14.5 %; p = 0.02), higher number of patients with high disease activity DAS28 score of ≥5.1 (20.0 versus 4.5 %; p = 0.01), lower age (54.5 versus 64.0 years; p = 0.003) and shorter disease duration (5.1 versus 10.3 years; p = 0.06). Deficiency of 25-hydroxyvitamin D3 was detected in 33.4 % of the RA patients. A subpopulation of patients with severe deficiency of vitamin D3 serum level of ≤15 nmol/l was characterised by all being positive for rheumatoid factor, high percentage of patients with very high disease activity and high percentage of patients treated with at least three DMARDs.

Keywords

Disease activity Rheumatoid arthritis Vitamin D3 (25-OH-D3

Notes

Acknowledgments

We are grateful for the excellent help given by the clinical and laboratory staff at the Department of Rheumatology at Sydvestjysk Sygehus, especially Dorte Terp Andersen, Lone Sommer, Karin Bundesen, Jytte Krause and Pia Rasmussen. We are grateful to the Kvinherrad Rheumatism Association and Stord Rheumatism Association for their funding of the project. We also thank the patients for their participation.

Disclosures

None.

References

  1. 1.
    Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new ethiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142PubMedCrossRefGoogle Scholar
  2. 2.
    Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 6:1678S–1688SGoogle Scholar
  3. 3.
    Deluca HF, Cantorna MT (2001) Vitamin D: its role and uses in immunology. FASEB J 15:2579–2589PubMedCrossRefGoogle Scholar
  4. 4.
    Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M (2003) Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha 25-dihydroxyvitamin D3 by human dendritic cells. Blood 102:2214–3316CrossRefGoogle Scholar
  5. 5.
    Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KW, Iowa Women’s Health Study (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 50:72–77PubMedCrossRefGoogle Scholar
  6. 6.
    Broder AR, Tobin JN, Putterman C (2010) Disease-specific definitions of Vitamin D deficiency need to be established in autoimmune and non-immune chronic diseases: a retrospective comparison of three chronic diseases. Arthritis Res Ther 12(5):R191PubMedCrossRefGoogle Scholar
  7. 7.
    Haque UJ, Bartlett SJ (2010) Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin Exp Rheumatol 28(5):745–747PubMedGoogle Scholar
  8. 8.
    Kerr GS, Sabahi I, Rchards JS, Caplan L, Cannon GW, Reimold A, Thiele GM, Johnson D, Mikuls TR (2011) Prevalence of vitamin D deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol 38(1):53–59PubMedCrossRefGoogle Scholar
  9. 9.
    Gopinath K, Danda D (2011) Supplementation f 1,25 dihydroxy vitamin D3 in patients with treatment naïve early rheumatoid arthritis: a randomized controlled trial. Int J Rheum Dis 14:332–339PubMedCrossRefGoogle Scholar
  10. 10.
    Oelzner P, Müller A, Deschner F, Hüller M, Abendroth K, Hein G, Stein G (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193–198PubMedCrossRefGoogle Scholar
  11. 11.
    Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Sulli A, Paolino S (2006) Seriolo B Circaannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24(6):702–704PubMedGoogle Scholar
  12. 12.
    Andjelkovic Z, Vojinovic J, Pejnovic N, Popovic M, Dujic A, Mitrovic D, Pavlica L, Stefanovic D (1999) Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17:453–456PubMedGoogle Scholar
  13. 13.
    Haque UJ, Bathon JM, Giles JT (2012) Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis. Arthritis Care Res 64(10):1497–1504. doi: 10.1002/acr.21715 CrossRefGoogle Scholar
  14. 14.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  15. 15.
    Kleveland G, Egeland T, Lea T (1988) Quantitation of rheumatoid factors (RF) of IgM, IgA and IgG isotypes by a simple and sensitive ELISA. Discrimination between false and true IgG-RF. Scand J Rheumatology (Suppl. 75):15–24Google Scholar
  16. 16.
    Mosekilde L, Nielsen LR, Larsen ER, Moosgaard B, Heichendorff L (2005) Vitamin D-mangel: definition og prævalens i Danmark. Dan Med Bull 167/1:29–33Google Scholar
  17. 17.
    Van Gestel AM, Stucki G (1999) Evaluation of established rheumatoid arthritis. Baillieres Clin Rheumatol 13:629–644CrossRefGoogle Scholar
  18. 18.
    Balsa A, Carmona L, Gonzalez-Alvaro I, Belmonte MA, Tena X, Sanmarti R, EMECAR Group (2004) Value of Disease Activity Score 28 (DAS28) and DAS 28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. J Rheumatol 31:4–46Google Scholar
  19. 19.
    Brot C, Vestergaard P, Kolthoff N, Gram J, Herman AP, Sørensen OH (2001) Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr 86(Suppl 1):S97–S103PubMedCrossRefGoogle Scholar
  20. 20.
    Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P (2010) Vitamin D levels and mortality in type 2 diabetes. Diabetes Care 33(10):2238–2243PubMedCrossRefGoogle Scholar
  21. 21.
    Gopinath K, Danda D (2011) Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naïve early rheumatoid arthritis: a randomized controlled trial. Rheum Dis 14:332–339CrossRefGoogle Scholar
  22. 22.
    Baker JF, Baker DG, Toedter G, Schultz J, Von Feldt JM, Leonard MB (2012) Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis. Clin Exp Rheumatol 30(5):658–664PubMedGoogle Scholar
  23. 23.
    Baker JF, Mehta NN, Baker DG, Toedter G, Von Feldt JM, Leonard MB (2012) Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis. Am J Med 125(10):1036.e9–1036.e15CrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2013

Authors and Affiliations

  • Hans-Jacob Haga
    • 1
  • Anne Schmedes
    • 2
  • Yusuf Naderi
    • 3
  • Alicia Martin Moreno
    • 4
  • Elisabeth Peen
    • 1
  1. 1.Reumaklinik DanmarkAalborg University EsbjergEsbjergDenmark
  2. 2.Department of Clinical BiochemistryLillebaelt HospitalVejleDenmark
  3. 3.Department of RheumatologySydvestjysk SygehusEsbjergDenmark
  4. 4.Department of UrologyThe National HospitalCopenhagenDenmark

Personalised recommendations